ArticleFrontiers in oncology2019

High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib.

Alessio Amatu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.